RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/11034353http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/11034353http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/11034353http://www.w3.org/2000/01/rdf-schema#comment"2B4 is an NK cell activation receptor that can provide a co-stimulatory signal to other activation receptors and whose mode of signal transduction is still unknown. We show that cross-linking of 2B4 on NK cells results in its rapid tyrosine phosphorylation, implying that this initial step in 2B4 signaling does not require coligation of other receptors. Ligation of 2B4 in the context of an NK cell-target cell interaction leads to 2B4 tyrosine phosphorylation, target cell lysis, and IFN-gamma release. Coligation of 2B4 with the inhibitory receptors killer cell Ig-like receptor (KIR)2DL1 or CD94/NKG2 completely blocks NK cell activation. The rapid tyrosine phosphorylation of 2B4 observed upon contact of NK cells with sensitive target cells is abrogated when KIR2DL1 or CD94/NKG2 are engaged by their cognate MHC class I ligand on resistant target cells. These results demonstrate that NK inhibitory receptors can interfere with a step as proximal as phosphorylation of an activation receptor."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.org/dc/terms/identifier"doi:10.4049/jimmunol.165.7.3545"xsd:string
http://purl.uniprot.org/citations/11034353http://purl.org/dc/terms/identifier"doi:10.4049/jimmunol.165.7.3545"xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/author"Watzl C."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/author"Watzl C."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/author"Long E.O."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/author"Long E.O."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/author"Stebbins C.C."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/author"Stebbins C.C."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/date"2000"xsd:gYear
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/date"2000"xsd:gYear
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/pages"3545-3548"xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/pages"3545-3548"xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/title"NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/title"NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)."xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/volume"165"xsd:string
http://purl.uniprot.org/citations/11034353http://purl.uniprot.org/core/volume"165"xsd:string
http://purl.uniprot.org/citations/11034353http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/11034353
http://purl.uniprot.org/citations/11034353http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/11034353
http://purl.uniprot.org/citations/11034353http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/11034353
http://purl.uniprot.org/citations/11034353http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/11034353